Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic‐gland type: A retrospective, matched case–control study
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Junnosuke Hayasaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Antacids, Stomach Neoplasms, Esophagitis, Peptic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Okinaka Memorial Institute for Medical Research.
Abstract (Originalsprache)
Background and Aim Since the first report of gastric adenocarcinoma of the fundic‐gland type in 2010, the clinicopathological characteristics of gastric neoplasm of the fundic‐gland type (GNFG) have become clearer; however, their risk factors remain unclear. This exploratory study aimed to identify the risk factors for GNFG.
Methods
We conducted a single‐center, retrospective, matched case–control study using medical information recorded at our health management center from January 2014 to July 2023. During this period, 39 240 people underwent upper gastrointestinal endoscopy. GNFG were extracted as cases and matched to controls, according to age and sex, in a 1:8 ratio, excluding those with a history of gastrointestinal surgery and those with a history or comorbidity of cancer. Univariate analysis was used to compare patient background and endoscopic findings. Multivariable analysis was performed, adjusting for factors with P values < 0.1 and antacid use.
Results
A total of 20 GNFG cases and 160 matched healthy controls were included. In the univariate analysis, only reflux esophagitis was significantly more common in GNFG (40.0% vs 18.1%; P = 0.036). Factors antacids and duodenitis had P values < 0.1. Logistic regression analysis was performed, adjusting for antacids, reflux esophagitis, and duodenitis. Antacids and reflux esophagitis were the independent risk factors for GNFG (odds ratio = 3.68 [95% confidence interval: 1.04–11.91] and 3.25 [95% confidence interval: 1.11–9.35]).
Conclusions
Although the sample of patients with GNFG was small, antacids and reflux esophagitis were identified as a risk factor. The pathogenesis of antacids and reflux esophagitis may be involved in the development of GNFG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
- Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
- Department of Pathology, Toranomon Hospital, Tokyo, Japan.
- Health Management Center, Toranomon Hospital, Tokyo, Japan.
ORCID-Profile: Junnosuke Hayasaka
Förderung
- Okinaka Memorial Institute for Medical Research
Zitieren
APA
Hayasaka, J., Hoteya, S., Takazawa, Y., Kikuchi, D., & Araki, A. (2024). Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic‐gland type: A retrospective, matched case–control study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16577
Vancouver
Hayasaka J, Hoteya S, Takazawa Y, Kikuchi D, Araki A. Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic‐gland type: A retrospective, matched case–control study. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16577
BibTeX
@article{Hayasaka2024,
author = {Hayasaka, Junnosuke and Hoteya, Shu and Takazawa, Yutaka and Kikuchi, Daisuke and Araki, Akihiro},
title = {Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic‐gland type: A retrospective, matched case–control study},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16577}
}
EUVIMED